MWA
EW icon

Marshall Wace Asia’s Edwards Lifesciences EW Stock Holding History

Marshall Wace Asia’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-80,910
Closed -$4.98M – 162
2019
Q2 		$4.98M Buy
+80,910
New +$4.89M 0.12% 74

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Marshall Wace Asia's EW Position: Q3 2019 in Review

Marshall Wace Asia sold out of Edwards Lifesciences (EW) in Q3 2019, closing a stake of 80,910 shares — an estimated $4.98M sold.

Marshall Wace Asia first reported a position in EW in Q2 2019 and held it in 1 quarter. The position peaked at $4.98M in Q2 2019. 964 funds tracked by Wall St. Rank hold EW as of Q3 2019.

  • Marshall Wace Asia reported no remaining Edwards Lifesciences position as of Q3 2019 after selling out during the quarter.
  • Marshall Wace Asia sold 80,910 Edwards Lifesciences shares in Q3 2019, an estimated $4.98M.
  • Marshall Wace Asia first reported a position in Edwards Lifesciences in Q2 2019 and held it in 1 quarter.
  • Marshall Wace Asia's Edwards Lifesciences position peaked at $4.98M in Q2 2019.
  • 964 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2019.

Based on Marshall Wace Asia's 13F filing for Q3 2019, filed 14 Nov 2019.